RU58841 – Powder, 5 grams

RU58841 (PSK-3841) is a non-steroidal androgen receptor (AR) antagonist developed to selectively inhibit AR-mediated signaling pathways. Experimental investigations have demonstrated that RU58841 competes with androgenic ligands for binding to the androgen receptor, preventing receptor activation and downstream transcriptional activity. Research has examined its interactions with AR-associated regulatory mechanisms, ligand-receptor dynamics, nuclear receptor signaling pathways, and transcriptional control processes governed by androgen receptor activation. Its well-characterized antagonist profile makes RU58841 a valuable research tool for studies of androgen receptor pharmacology, AR-mediated signal transduction, receptor-ligand competition, nuclear receptor regulation, and comparative investigations of androgen receptor antagonists.